Interactive evaluation of resonance sonomanometry for tripartite collaboration (CUC Inc. × TOKI Trading × Esperto) benchmarked across continuous blood pressure and hemodynamic technologies.
Select nodes or vectors to examine operational, hardware, and regional synergies
CUC’s clinical operations across acute hospitals, outpatient clinics, in-center hemodialysis units, and palliative home nursing homes offer ideal clinical validation cohorts for continuous non-invasive blood pressure monitoring.
Relieving elderly hemodialysis patients from painful periodic cuff inflations while catching intradialytic hypotension before nauseating hypoperfusion occurs; preventing sleep disruptions in hospice patients.
Requires continuous acoustic coupling (hydrogel pad) and stable anatomical beam placement over the brachial artery. Transducer misalignment during arm movement requires automatic re-acquisition or signal quality indexing.
Exploratory interest only. No binding pilot agreement or PMDA-cleared investigational protocol exists. Nursing staff acceptance must be measured against automated oscillometric cuffs.
Exhaustive benchmarking of acoustic, optical, mechanical, ultrasound, and bioimpedance modalities
| Device / Platform | Primary Modality | Directness to Pressure | Cuff Calibration | Motion Artifact Tolerance | Regulatory & Market Status | Action |
|---|
Observe how sensor physics respond under real-world clinical stressors compared to an invasive Arterial Line
Under Vasopressor Titration (Phenylephrine), smooth muscle contraction decouples pulse wave transit time (PWTT) from true hydrostatic pressure, causing Optical PPG to dramatically underestimate systolic spikes by 15–28 mmHg without prompt oscillometric recalibration. In contrast, Resonance Sonomanometry tracks arterial wall vibration frequency shifts directly linked to wall tension, preserving trackability if acoustic beam alignment is preserved.
Disentangling two prominent wearable ultrasound spinouts across clinical and strategic vectors
For meetings with Keita Hamaguchi & Clinical Operations Team
Will the pilot evaluate in-center hemodialysis (catching intradialytic hypotension) or Tokyo Family Clinic palliative home nursing (eliminating nocturnal cuff pain)?
Can bedside nurses maintain acoustic coupling gel pads without spending more than 2 minutes per patient shift? What rate of signal dropout triggers monitor abandonment?
Who writes the purchasing check—the nephrology department head, clinic director, or central hospital procurement? What exact clinical outcome (e.g. 30% reduction in IDH events) justifies equipment lease?
For meetings with Sachiko Takehiro & Engineering Team
What is the measured milliwatt power consumption and skin contact heating during 8-hour continuous acoustic excitation? Does it satisfy IEC 60601-1 thermal limits (<41°C)?
What is the total manufacturing cost of the dual-transducer assembly? What is the daily per-patient cost of disposable adhesive coupling hydrogel pads?
Will TOKI supply sub-components (power adapters, shielded medical cables), or act as the formal marketing authorization holder (MAH / 製造販売業者) for PMDA clearance in Japan?